NeuroPace, Inc. (NPCE)
13.00
+0.33
(+2.60%)
USD |
NASDAQ |
Oct 12, 16:00
12.98
-0.02
(-0.15%)
Pre-Market: 20:00
NeuroPace Free Cash Flow : -11.61M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -11.61M |
| March 31, 2026 | -9.836M |
| December 31, 2025 | -11.34M |
| September 30, 2025 | -16.58M |
| June 30, 2025 | -16.43M |
| March 31, 2025 | -18.14M |
| December 31, 2024 | -18.26M |
| September 30, 2024 | -16.79M |
| June 30, 2024 | -17.28M |
| March 31, 2024 | -17.68M |
| December 31, 2023 | -19.87M |
| September 30, 2023 | -24.45M |
| Date | Value |
|---|---|
| June 30, 2023 | -29.14M |
| March 31, 2023 | -35.60M |
| December 31, 2022 | -37.47M |
| September 30, 2022 | -37.88M |
| June 30, 2022 | -35.48M |
| March 31, 2022 | -30.69M |
| December 31, 2021 | -24.96M |
| September 30, 2021 | -23.07M |
| June 30, 2021 | -23.90M |
| March 31, 2021 | -21.08M |
| December 31, 2020 | -21.67M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| CVRx, Inc. | -41.05M |
| Accuray, Inc. | -19.26M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | -26.93M |
| ResMed, Inc. | 1.629B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.903M |
| Cash from Investing (Quarterly) | -0.125M |
| Cash from Financing (Quarterly) | 1.176M |
| Free Cash Flow Per Share (Quarterly) | -0.1181 |
| Free Cash Flow to Equity (Quarterly) | -3.497M |
| Free Cash Flow to Firm (Quarterly) | -2.489M |
| Free Cash Flow Yield | -2.66% |